Timing of Repeat Colonoscopy. Disparity Between Guidelines and Endoscopists' Recommendation

American Journal of Preventive Medicine

Volumn 33, Issue 6, 2007, Pages 471-478

  Krist, Alex H ^a,b   Jones, Resa M ^a,e,f   Woolf, Steven H ^a   Woessner, Sarah E ^b   Merenstein, Daniel ^g   Kerns, J William ^a,c   Foliaco, Walter ^d   Jackson, Paul ^e  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b Fairfax Family Practice Residency   (United States)

^c Shenandoah Family Practice Residency   (United States)

^d Chesterfield Family Practice   (United States)

^e St Francis Family Medicine Residency   (United States)

^f VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^g GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMATOUS POLYP; ARTICLE; COLONOSCOPY; GASTROINTESTINAL ENDOSCOPY; HUMAN; MEDICAL PRACTICE; MEDICAL RECORD; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; POLYP; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; RANDOM SAMPLE; RISK FACTOR; UNITED STATES;

AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 36048971674     PISSN: 07493797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amepre.2007.07.039     Document Type: Article

References (48)

1. Pignone M., Rich M., Teutsch S.M., Berg A.O., and Lohr K.N. Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 137 (2002) 132-141
2. Colorectal cancer screening. Recommendation statement from the Canadian Task Force on Preventive Health Care. CMAJ 165 (2006) 206-208
3. Pignone M., Saha S., Hoerger T., and Mandelblatt J. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 137 (2002) 96-104
4. Screening for colorectal cancer: recommendation and rationale. Ann Intern Med 137 (2002) 129-131
5. Walsh J.M., and Terdiman J.P. Colorectal cancer screening: scientific review. JAMA 289 (2003) 1288-1296
6. Winawer S.J., Zauber A.G., Ho M.N., et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 329 (1993) 1977-1981
7. Citarda F., Tomaselli G., Capocaccia R., Barcherini S., and Crespi M. Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut 48 (2001) 753-754
8. Atkin W.S., Morson B.C., and Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med 326 (1992) 658-662
9. Thiis-Evensen E., Hoff G.S., Sauar J., Langmark F., Majak B.M., and Vatn M.H. Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scand J Gastroenterol 34 (1999) 414-420
10. Newcomb P.A., Storer B.E., Morimoto L.M., Templeton A., and Potter J.D. Long-term efficacy of sigmoidoscopy in the reduction of colorectal cancer incidence. J Natl Cancer Inst 95 (2003) 622-625
11. Bertario L., Russo A., Sala P., et al. Predictors of metachronous colorectal neoplasms in sporadic adenoma patients. Int J Cancer 105 (2003) 82-87
12. Lieberman D.A., Weiss D.G., Bond J.H., Ahnen D.J., Garewal H., and Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med 343 (2000) 162-168
13. Imperiale T.F., Wagner D.R., Lin C.Y., Larkin G.N., Rogge J.D., and Ransohoff D.F. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med 343 (2000) 169-174
14. Yousfi M., Gostout C.J., Baron T.H., et al. Postpolypectomy lower gastrointestinal bleeding: potential role of aspirin. Am J Gastroenterol 99 (2004) 1785-1789
15. Cobb W.S., Heniford B.T., Sigmon L.B., et al. Colonoscopic perforations: incidence, management, and outcomes. Am Surg 70 (2004) 750-757 discussion 757-8
16. Misra T., Lalor E., and Fedorak R.N. Endoscopic perforation rates at a Canadian university teaching hospital. Can J Gastroenterol 18 (2004) 221-226
17. Nelson D.B., McQuaid K.R., Bond J.H., Lieberman D.A., Weiss D.G., and Johnston T.K. Procedural success and complications of large-scale screening colonoscopy. Gastrointest Endosc 55 (2002) 307-314
18. Levin T.R., Zhao W., Conell C., et al. Complications of colonoscopy in an integrated health care delivery system. Ann Intern Med 145 (2006) 880-886
19. Ransohoff D.F. Colon cancer screening in 2005: status and challenges. Gastroenterology 128 (2005) 1685-1695
20. Sirovich B.E., Schwartz L.M., and Woloshin S. Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence?. JAMA 289 (2003) 1414-1420
21. Vijan S., Inadomi J., Hayward R.A., Hofer T.P., and Fendrick A.M. Projections of demand and capacity for colonoscopy related to increasing rates of colorectal cancer screening in the United States. Aliment Pharmacol Ther 20 (2004) 507-515
22. Ladabaum U., and Song K. Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand. Gastroenterology 129 (2005) 1151-1162
23. Winawer S.J., Fletcher R.H., Miller L., et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 112 (1997) 594-642
24. Winawer S., Fletcher R., Rex D., et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology 124 (2003) 544-560
25. Winawer S.J., Zauber A.G., Fletcher R.H., et al. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the U.SMulti-Society Task Force on Colorectal Cancer and the American Cancer Society. CA Cancer J Clin 56 (2006) 143-159 quiz 184-5
26. Mysliwiec P.A., Brown M.L., Klabunde C.N., and Ransohoff D.F. Are physicians doing too much colonoscopy?. A national survey of colorectal surveillance after polypectomy. Ann Intern Med 141 (2004) 264-271
27. Starfield B., Shi L., and Macinko J. Contribution of primary care to health systems and health. Milbank Q 83 (2005) 457-502
28. Tyler Jr. C.V., and Snyder C.W. Cancer risk assessment: examining the family physician's role. J Am Board Fam Med 19 (2006) 468-477
29. Kleinbaum D.G., Kupper L.L., Muller K.E., and Nizam A. Applied regression analysis and multivariable methods. 3rd edn. (1998), Duxbury Press, Boston
30. Behavioral Risk Factor Surveillance System: Prevalence Data: National Center for Chronic Disease Prevention and Health Promotion, 2007. Available online at: http://apps.nccd.cdc.gov/brfss/index.asp.
31. Schoenfeld P., Cash B., Flood A., et al. Colonoscopic screening of average-risk women for colorectal neoplasia. N Engl J Med 352 (2005) 2061-2068
32. Woolf S.H. Potential health and economic consequences of misplaced priorities. JAMA 297 (2007) 523-526
33. Schwartz L.M., Woloshin S., Fowler Jr. F.J., and Welch H.G. Enthusiasm for cancer screening in the United States. JAMA 291 (2004) 71-78
34. Benefits foregone: too much of the wrong and too little of the right. Based on a presentation by Bernard S. Bloom PhD. Am J Manag Care 5 6 Suppl (1999) S355-S360
35. McGlynn E.A., Asch S.M., Adams J., et al. The quality of health care delivered to adults in the United States. N Engl J Med 348 (2003) 2635-2645
36. Woolf S.H., and Krist A. The liability of giving patients a choice: shared decision making and prostate cancer. Am Fam Physician 71 (2005) 1871-1872
37. Ardery G., Carter B.L., Milchak J.L., et al. Explicit and implicit evaluation of physician adherence to hypertension guidelines. J Clin Hypertens 9 (2007) 113-119 (Greenwich)
38. Flanders S.A., and Halm E.A. Guidelines for community-acquired pneumonia: are they reflected in practice?. Treat Respir Med 3 (2004) 67-77
39. Schers H., Wensing M., Huijsmans Z., van Tulder M., and Grol R. Implementation barriers for general practice guidelines on low back pain a qualitative study. Spine 26 (2001) E348-E353
40. McAlister F.A., Campbell N.R., Zarnke K., Levine M., and Graham I.D. The management of hypertension in Canada: a review of current guidelines, their shortcomings and implications for the future. CMAJ 164 (2001) 517-522
41. Seeff L.C., Manninen D.L., Dong F.B., et al. Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States?. Gastroenterology 127 (2004) 1661-1669
42. Seeff L.C., Richards T.B., Shapiro J.A., et al. How many endoscopies are performed for colorectal cancer screening?. Results from CDC's survey of endoscopic capacity. Gastroenterology 127 (2004) 1670-1677
43. Colorectal cancer: health professionals facts on screening (2000), Centers for Disease Control and Prevention, Washington DC. http://www.cdc.gov/cancer/colorectal/pdf/fs-professional.pdf Available online at: http://www.cdc.gov/cancer/colorectal/pdf/fs-professional.pdf.
44. Butterly L., Olenec C., Goodrich M., Carney P., and Dietrich A. Colonoscopy demand and capacity in New Hampshire. Am J Prev Med 32 (2007) 25-31
45. Murff H.J., Patel V.L., Hripcsak G., and Bates D.W. Detecting adverse events for patient safety research: a review of current methodologies. J Biomed Inform 36 (2003) 131-143
46. Worster A., and Haines T. Advanced statistics: understanding medical record review (MRR) studies. Acad Emerg Med 11 (2004) 187-192
47. Camacho L.A., and Rubin H.R. Assessment of the validity and reliability of three systems of medical record screening for quality of care assessment. Med Care 36 (1998) 748-751
48. Barclay R.L., Vicari J.J., Doughty A.S., Johanson J.F., and Greenlaw R.L. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N Engl J Med 355 (2006) 2533-2541